argenx stock: Management sets two November investor events
Published on 11/03/2026 at 10:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSNovember events set investor focus
- argenx management will join a Guggenheim healthcare conference in Boston on November 10.
- A second fireside chat is scheduled for the Jefferies London Global Healthcare Conference on November 17.
- Both presentations are expected to be available as live webcasts and replays.
argenx announced on Tuesday, November 3, that members of its management team will participate in two healthcare investor conferences this month. The company said the appearances will give investors access to management discussions in Boston and London.
Two conferences in November
The first event is the Guggenheim 3rd Annual Healthcare Innovation Conference in Boston. argenx management is scheduled for a fireside chat on Tuesday, November 10, at 2:00 p.m. Eastern Time.
The second appearance is set for the Jefferies London Global Healthcare Conference on Tuesday, November 17, at 8:30 a.m. Greenwich Mean Time. The company made the announcement in a press release carried by GlobeNewswire.
argenx said live webcasts may be accessed through its investor website, with replays available for approximately 30 days after each presentation. The format gives investors a scheduled opportunity to hear management discuss the immunology portfolio and development pipeline, although the announcement did not provide new financial guidance.
Clinical catalysts remain ahead
The conference schedule comes as the company prepares for further clinical attention on efgartigimod and its broader autoimmune pipeline. The next investor focus is likely to be management's comments on commercial execution, regulatory progress and the potential expansion of the VYVGART franchise.
argenx stock traded at 782.80 euros on Lang & Schwarz at 10:38 CET on Tuesday, November 3. The quote is available through the real-time quote of argenx stock.
argenx at a glance
- Company: argenx SE
- ISIN: NL0010832176
- Ticker: ARGX
- Primary listing: Euronext and Nasdaq
- Sector: Healthcare
- Industry: Biotechnology
- Lang & Schwarz quote: 782.80 euros at 10:38 CET on November 3, 2026
The wider European market backdrop can be followed through current AEX market reports.
Further company developments are available in more news and analyses on argenx stock.
